Corton Capital’s Regenxbio RGNX Stock Holding History

Corton Capital’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,528	Closed	-$147K	–	392
2025 Q1	$147K	Buy	20,528 +7,252	+55%	+$53.9K	0.49%	94
2024 Q4	$103K	Buy	+13,276	New	+$125K	0.06%	346

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Corton Capital's RGNX Position: Q2 2025 in Review

Corton Capital sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 20,528 shares — an estimated $147K sold.

Corton Capital first reported a position in RGNX in Q4 2024 and held it in 2 quarters. The position peaked at $147K in Q1 2025. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

Corton Capital reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
Corton Capital sold 20,528 Regenxbio shares in Q2 2025, an estimated $147K.
Corton Capital first reported a position in Regenxbio in Q4 2024 and held it in 2 quarters.
Corton Capital's Regenxbio position peaked at $147K in Q1 2025.
159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Corton Capital's 13F filing for Q2 2025, filed 5 Aug 2025.